Clinical Trials Logo

Clinical Trial Summary

Background. Cancer is the leading cause of death by disease in children. Most pediatric tumors differ from adult tumors in terms of biological and clinical characteristics. In children, the part of genetic determinism could be higher since the role of environmental factors may be less pronounced than in adults and that a young age at onset is a main feature of genetic cancer predisposition. Recent studies suggested that a number of genetic predisposition remains to be characterized. Methods. Trio-Based whole exome sequencing of germline DNA from patients (children and adults diagnosed with cancers between 0 and 17 years) and parents will be performed prospectively in a multicentric study including 40 unselected cases of malignant tumor. Participating hospitals will include the CHU of Montpellier, the CHU de Nice and the AP-HP. Tumor analysis will include whole exome analysis and transcriptome for the identification of therapeutic target and contribute to confirm potential link between constitutive mutations and tumor phenotype (such as loss of expression, loss of heterozygosity). Perspectives. This pediatric oncology study proposing a global approach integrating trio-based whole exome sequencing, somatic DNA and RNA analysis will improve the recognition of genetic predisposition and the characterization of target therapies in children with cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04471961
Study type Interventional
Source University Hospital, Montpellier
Contact Pascal Pujol, PU-PH
Phone +33 4 67 33 58 75
Email p-pujol@chu-montpellier.fr
Status Recruiting
Phase N/A
Start date July 9, 2020
Completion date December 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03936465 - Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer Phase 1
Recruiting NCT04899505 - Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology
Recruiting NCT03465592 - Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma Phase 1/Phase 2
Recruiting NCT03373656 - Vaccination for Children of H&O and Their Parents N/A
Recruiting NCT05481502 - An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors N/A
Recruiting NCT05042479 - Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. N/A
Recruiting NCT04485416 - Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors Phase 1
Recruiting NCT03086421 - Social Emotional Development in Young Children With Cancer
Recruiting NCT04381221 - Observational MyPal-Child Study on the ePRO-based Early Palliative Care Digital System in Paediatric Oncology Patients
Terminated NCT04671901 - A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Phase 2
Not yet recruiting NCT05633719 - Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer